Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Galapagos and Gilead announce positive Phase III results for filgotinib

pharmaceutical-technologyApril 23, 2019

Tag: Galapagos , gilead , filgotinib , MTX

PharmaSources Customer Service